JGP Wealth Management LLC Acquires 44 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

JGP Wealth Management LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,095 shares of the medical equipment provider’s stock after acquiring an additional 44 shares during the quarter. JGP Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,094,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in ISRG. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter worth approximately $38,000. Finally, DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG stock opened at $584.08 on Friday. Intuitive Surgical, Inc. has a twelve month low of $355.17 and a twelve month high of $585.50. The business has a fifty day simple moving average of $538.34 and a 200 day simple moving average of $497.08. The company has a market cap of $208.04 billion, a P/E ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ISRG. Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.